Cargando…

Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin

SIMPLE SUMMARY: Men with metastatic castration-resistant prostate cancer (mCRPC) have shorter overall survival and resist therapy faster if their blood have a poor lipid profile. This poor lipid profile includes high levels of sphingolipids, thus reducing these sphingolipids may slow prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mak, Blossom, Lin, Hui-Ming, Duong, Thy, Mahon, Kate L., Joshua, Anthony M., Stockler, Martin R., Gurney, Howard, Parnis, Francis, Zhang, Alison, Scheinberg, Tahlia, Wittert, Gary, Butler, Lisa M., Sullivan, David, Hoy, Andrew J., Meikle, Peter J., Horvath, Lisa G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563053/ https://www.ncbi.nlm.nih.gov/pubmed/36230715 http://dx.doi.org/10.3390/cancers14194792

Ejemplares similares

Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer
por: Mak, Blossom, et al.
Publicado: (2022)

Targeting lipid metabolism in metastatic prostate cancer
por: Scheinberg, Tahlia, et al.
Publicado: (2023)

Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer
por: Lin, Hui-Ming, et al.
Publicado: (2017)

Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)
por: Scheinberg, Tahlia, et al.
Publicado: (2020)

Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
por: Lin, Hui-Ming, et al.
Publicado: (2021)

The Impact of Simvastatin on Lipidomic Markers of Cardiovascular Risk in Human Liver Cells Is Secondary to the Modulation of Intracellular Cholesterol
por: Schooneveldt, Yvette L., et al.
Publicado: (2021)

Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer
por: Lin, Hui-Ming, et al.
Publicado: (2021)

Effect of simvastatin on castration-resistant prostate cancer cells
por: Kim, Jenny Hanbi, et al.
Publicado: (2014)

Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study
por: Kaddurah-Daouk, Rima, et al.
Publicado: (2010)

Influence of the Human Lipidome on Epicardial Fat Volume in Mexican American Individuals
por: Leandro, Ana Cristina, et al.
Publicado: (2022)

Clinical lipidomics: realizing the potential of lipid profiling
por: Meikle, Thomas G., et al.
Publicado: (2021)

Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer
por: Miladinovic, Dushan, et al.
Publicado: (2020)

Changes in plasma lipidome following initiation of antiretroviral therapy
por: Trevillyan, Janine M., et al.
Publicado: (2018)

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
por: Lin, H-M, et al.
Publicado: (2014)

Plasma Lipidomic Profiling of Treated HIV-Positive Individuals and the Implications for Cardiovascular Risk Prediction
por: Wong, Gerard, et al.
Publicado: (2014)

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer
por: Mahon, K L, et al.
Publicado: (2014)

Immunometabolic and Lipidomic Markers Associated With the Frailty Index and Quality of Life in Aging HIV+ Men on Antiretroviral Therapy
por: Yeoh, Hui-Ling, et al.
Publicado: (2017)

GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)
por: Conduit, Ciara, et al.
Publicado: (2022)

Case Series: “Silent” Spinal Epidural Metastases in Metastatic Castrate-Resistant Prostate Cancer
por: Sabanathan, Dhanusha, et al.
Publicado: (2023)

Lipidomics Reveals a Tissue-Specific Fingerprint
por: Pradas, Irene, et al.
Publicado: (2018)

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer
por: Mahon, K L, et al.
Publicado: (2015)

Simvastatin delays castration-resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin-1
por: Gao, Yingying, et al.
Publicado: (2019)

The Effects of Long-Term Saturated Fat Enriched Diets on the Brain Lipidome
por: Giles, Corey, et al.
Publicado: (2016)

Molecular mechanisms for simvastatin-mediated enhancement of synaptic plasticity
por: Mans, Robert A, et al.
Publicado: (2012)

Clinical lipidomics – A community-driven roadmap to translate research into clinical applications
por: Vvedenskaya, Olga, et al.
Publicado: (2022)

Unravelling Prostate Cancer Heterogeneity Using Spatial Approaches to Lipidomics and Transcriptomics
por: Mutuku, Shadrack M., et al.
Publicado: (2022)

Lipidomic dataset of plasma from patients infected with wild type and nef-deficient HIV-1 strain
por: Meikle, Peter, et al.
Publicado: (2015)

Simvastatin causes pulmonary artery relaxation by blocking smooth muscle ROCK and calcium channels: Evidence for an endothelium-independent mechanism
por: Absi, Mais, et al.
Publicado: (2019)

Lipidomic Profiling Identifies Serum Lipids Associated with Persistent Multisite Musculoskeletal Pain
por: Ma, Canchen, et al.
Publicado: (2022)

Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer
por: Kohli, Manish, et al.
Publicado: (2020)

Lipidomic Profiling of Murine Macrophages Treated with Fatty Acids of Varying Chain Length and Saturation Status
por: Huynh, Kevin, et al.
Publicado: (2018)

Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
por: Rotella, Carlo M, et al.
Publicado: (2010)

Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment
por: Attard, Gerhardt, et al.
Publicado: (2018)

Investigating Global Lipidome Alterations with the Lipid Network Explorer
por: Köhler, Nikolai, et al.
Publicado: (2021)

High-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: Evidence from two large population cohort studies
por: Beyene, Habtamu B., et al.
Publicado: (2020)

Lipidomics unveils the complexity of the lipidome in metabolic diseases
por: Lydic, Todd A., et al.
Publicado: (2018)

Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer
por: Kwan, Edmond M., et al.
Publicado: (2021)

Advances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapy
por: Pham, Thy, et al.
Publicado: (2016)

Current perspectives on the optimal age to spay/castrate dogs and cats
por: Howe, Lisa M
Publicado: (2015)

Shared reference materials harmonize lipidomics across MS-based detection platforms and laboratories
por: Triebl, Alexander, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1i9u3oerijpp6v1btamee6qkdj